The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global adhesion barriers market was valued at US$ 913 Million in 2021.
We expect the global adhesion barriers market to exhibit a CAGR of 7.07% during 2022-2027.
The rising healthcare expenditures, along with the growing demand for adhesion barriers in preventing
high risk of postoperative complications, are primarily driving the global adhesion barriers market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of numerous elective
surgeries, such as gynecological, general, cardiovascular, etc., to reduce the risk of the coronavirus
infection upon hospital visits, thereby limiting the demand for adhesion barriers.
Based on the product, the global adhesion barriers market can be segmented into synthetic and natural.
Currently, synthetic adhesion barriers hold the majority of the total market share.
Based on the formulation, the global adhesion barriers market has been divided into film, liquid, and gel.
Among these, film formulation currently exhibits a clear dominance in the market.
Based on the application, the global adhesion barriers market can be categorized into gynecological
surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological
surgeries, reconstructive surgeries, urological surgeries, and others. Currently, gynecological surgeries
account for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global adhesion barriers market include Anika Therapeutics, Inc.,
Atrium Medical Corporation, Baxter International, Inc., Betatech Medical, C. R. Bard, Inc., FzioMed, Inc.,
LifeSciences Corporation, Medical Devices Business Services, Inc., MAST Biosurgery Inc., Groupe Sanofi,
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at